{"id":"https://openalex.org/W1974086743","doi":"https://doi.org/10.1021/jm100602m","title":"Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges","display_name":"Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges","publication_year":2010,"publication_date":"2010-08-05","ids":{"openalex":"https://openalex.org/W1974086743","doi":"https://doi.org/10.1021/jm100602m","mag":"1974086743","pmid":"https://pubmed.ncbi.nlm.nih.gov/20687610"},"language":"en","primary_location":{"id":"doi:10.1021/jm100602m","doi":"https://doi.org/10.1021/jm100602m","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm100602m","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050156017","display_name":"Eunice N. Murage","orcid":"https://orcid.org/0000-0001-9630-3046","observed_orcids":["https://orcid.org/0000-0001-9630-3046"]},"institutions":[{"id":"https://openalex.org/I162577319","display_name":"The University of Texas at Dallas","ror":"https://ror.org/049emcs32","country_code":"US","type":"education","lineage":["https://openalex.org/I162577319"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eunice N. Murage","raw_affiliation_strings":["Department of Chemistry, University of Texas at Dallas, Richardson, Texas 75080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Texas at Dallas, Richardson, Texas 75080","institution_ids":["https://openalex.org/I162577319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020831456","display_name":"Guangzu Gao","orcid":"https://orcid.org/0000-0001-8182-4842","observed_orcids":["https://orcid.org/0000-0001-8182-4842"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guangzu Gao","raw_affiliation_strings":["Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013228845","display_name":"Alessandro Bisello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandro Bisello","raw_affiliation_strings":["Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081196478","display_name":"Jung\u2010Mo Ahn","orcid":"https://orcid.org/0000-0002-9104-525X","observed_orcids":["https://orcid.org/0000-0002-9104-525X"]},"institutions":[{"id":"https://openalex.org/I162577319","display_name":"The University of Texas at Dallas","ror":"https://ror.org/049emcs32","country_code":"US","type":"education","lineage":["https://openalex.org/I162577319"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jung-Mo Ahn","raw_affiliation_strings":["Department of Chemistry, University of Texas at Dallas, Richardson, Texas 75080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Texas at Dallas, Richardson, Texas 75080","institution_ids":["https://openalex.org/I162577319"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5081196478"],"corresponding_institution_ids":["https://openalex.org/I162577319"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.8948,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.90628072,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"53","issue":"17","first_page":"6412","last_page":"6420"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.35280001163482666,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9010000228881836},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8899999856948853},{"id":"https://openalex.org/keywords/lactam-bridge","display_name":"lactam bridge","score":0.9559999704360962},{"id":"https://openalex.org/keywords/conformationally-constrained-peptides","display_name":"conformationally constrained peptides","score":0.9129999876022339},{"id":"https://openalex.org/keywords/neutral-endopeptidase-24-11","display_name":"neutral endopeptidase 24.11","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dipeptidyl-peptidase-4","display_name":"dipeptidyl peptidase IV","score":0.7179999947547913},{"id":"https://openalex.org/keywords/enzyme-resistance","display_name":"enzyme resistance","score":0.7599999904632568},{"id":"https://openalex.org/keywords/peptide-stability","display_name":"peptide stability","score":0.746999979019165},{"id":"https://openalex.org/keywords/alpha-helix-stabilization","display_name":"alpha-helix stabilization","score":0.7649999856948853},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8330000042915344},{"id":"https://openalex.org/keywords/receptor-activation","display_name":"receptor activation","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.844202995300293},{"id":"https://openalex.org/C2776131168","wikidata":"https://www.wikidata.org/wiki/Q251124","display_name":"Lactam","level":2,"score":0.6544395685195923},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6150011420249939},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5842224955558777},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5709100961685181},{"id":"https://openalex.org/C2777774944","wikidata":"https://www.wikidata.org/wiki/Q417262","display_name":"Endopeptidase","level":3,"score":0.545372724533081},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.5139660239219666},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.5072781443595886},{"id":"https://openalex.org/C104826730","wikidata":"https://www.wikidata.org/wiki/Q414232","display_name":"Neprilysin","level":3,"score":0.4870064854621887},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.45338380336761475},{"id":"https://openalex.org/C2991874392","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Metabolic stability","level":3,"score":0.451641321182251},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4185996651649475},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4072742462158203},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07046392560005188},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002942","descriptor_name":"Circular Dichroism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012996","descriptor_name":"Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015260","descriptor_name":"Neprilysin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D017433","descriptor_name":"Protein Structure, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm100602m","doi":"https://doi.org/10.1021/jm100602m","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm100602m","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:20687610","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20687610","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W1540732733","https://openalex.org/W1576285254","https://openalex.org/W1607188212","https://openalex.org/W1964212912","https://openalex.org/W1968246808","https://openalex.org/W1969759659","https://openalex.org/W1976503602","https://openalex.org/W1977680116","https://openalex.org/W1978953702","https://openalex.org/W1978999164","https://openalex.org/W1986331352","https://openalex.org/W1986522335","https://openalex.org/W1987182389","https://openalex.org/W1989258777","https://openalex.org/W1990332976","https://openalex.org/W1992074689","https://openalex.org/W1994636940","https://openalex.org/W1997514666","https://openalex.org/W1998236525","https://openalex.org/W2001391476","https://openalex.org/W2003786134","https://openalex.org/W2004201419","https://openalex.org/W2013082477","https://openalex.org/W2013962155","https://openalex.org/W2017887262","https://openalex.org/W2022101780","https://openalex.org/W2025237740","https://openalex.org/W2026178423","https://openalex.org/W2033664726","https://openalex.org/W2037815969","https://openalex.org/W2038214413","https://openalex.org/W2040231456","https://openalex.org/W2042148434","https://openalex.org/W2045849794","https://openalex.org/W2049222364","https://openalex.org/W2057891684","https://openalex.org/W2068183831","https://openalex.org/W2074002745","https://openalex.org/W2078171783","https://openalex.org/W2079355745","https://openalex.org/W2080128749","https://openalex.org/W2081392051","https://openalex.org/W2082604269","https://openalex.org/W2083473802","https://openalex.org/W2086238197","https://openalex.org/W2092824081","https://openalex.org/W2094606841","https://openalex.org/W2097135163","https://openalex.org/W2098934646","https://openalex.org/W2104763836","https://openalex.org/W2108771199","https://openalex.org/W2109157463","https://openalex.org/W2109517949","https://openalex.org/W2118100404","https://openalex.org/W2120332046","https://openalex.org/W2132802847","https://openalex.org/W2145266416","https://openalex.org/W2146333376","https://openalex.org/W2154292631","https://openalex.org/W2155198744","https://openalex.org/W2168998958","https://openalex.org/W2169503005","https://openalex.org/W2328508385","https://openalex.org/W2461739114"],"related_works":["https://openalex.org/W2110093287","https://openalex.org/W2139006153","https://openalex.org/W2074002745","https://openalex.org/W2010874570","https://openalex.org/W2059105549","https://openalex.org/W2023015892","https://openalex.org/W2056594490","https://openalex.org/W3132709478","https://openalex.org/W2114369058","https://openalex.org/W4282831524"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"(GLP-1)":[2],"has":[3],"the":[4,8,23,63,95,105,114,122,141],"ability":[5],"to":[6,70,103,110],"lower":[7],"blood":[9],"glucose":[10],"level,":[11],"and":[12,39,79,97],"its":[13,30,46],"regulatory":[14],"functions":[15],"make":[16],"it":[17,68],"an":[18],"attractive":[19],"therapeutic":[20],"agent":[21],"for":[22,118],"treatment":[24],"of":[25,133,144],"type":[26],"2":[27],"diabetes.":[28],"However,":[29],"rapid":[31],"degradation":[32],"by":[33,85,112],"enzymes":[34],"like":[35],"dipeptidyl":[36],"peptidase-IV":[37],"(DPP-IV)":[38],"neutral":[40],"endopeptidase":[41],"(NEP)":[42],"24.11":[43,58,131],"severely":[44],"compromises":[45],"effective":[47],"clinical":[48],"use.":[49],"Whereas":[50],"specific":[51],"DPP-IV":[52],"inhibitors":[53],"have":[54,77],"been":[55],"developed,":[56],"NEP":[57,130,145],"targets":[59],"multiple":[60,87],"sites":[61],"in":[62,94],"GLP-1":[64,83,147],"sequence,":[65],"which":[66],"makes":[67],"difficult":[69],"block.":[71],"To":[72],"address":[73],"this":[74],"drawback,":[75],"we":[76],"designed":[78],"synthesized":[80],"conformationally":[81],"constrained":[82,138],"analogues":[84],"introducing":[86],"lactam":[88,124],"bridges":[89,125],"that":[90],"stabilized":[91],"both":[92],"alpha-helices":[93],"N-":[96],"C-terminal":[98],"regions":[99],"simultaneously.":[100],"In":[101],"addition":[102],"improving":[104],"receptor":[106,120],"activation":[107],"capability":[108],"(up":[109],"5-fold)":[111],"fixing":[113],"alpha-helical":[115],"conformations":[116],"required":[117],"optimal":[119],"interaction,":[121],"introduced":[123],"provided":[126],"outstanding":[127],"shielding":[128],"over":[129],"(half-life":[132],">96":[134],"h).":[135],"These":[136],"highly":[137],"peptides":[139],"are":[140],"first":[142],"examples":[143],"24.11-resistant":[146],"analogues.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}